Cephalothin (DBL) is a medicine containing the active ingredient(s) cefalotin. On this page you will find out more about Cephalothin (DBL), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: cefalotin
Information for medicine and pack size:
Cephalothin (DBL) 1 g powder for injection, 10 vials
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
INDICATIONS: Cephalothin Sodium for injection is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. Culture and susceptibility studies should be performed. However, therapy may be instituted before results of susceptibility studies are obtained (see PHARMACOLOGY: Microbiology). Respiratory tract: Infections caused by S. pneumoniae, Staphylococci (penicillinase and nonpenicillinase producing), group A Beta-haemolytic Streptococci, Klebsiella, and H. influenzae. Skin and soft tissue: Infections, including peritonitis, caused by Staphylococci (penicillinase and nonpenicillinase producing), group A Beta-haemolytic Streptococci, E.coli, Pr. mirabilis and Klebsiella. Genitourinary tract: Infections caused by E. coli, Pr. mirabilis and Klebsiella. Septicaemia, including endocarditis: Infections caused by S. pneumoniae, Staphylococci (penicillinase and nonpenicillinase producing), group A Beta-haemolytic Streptococci, S. viridans, E. coli, Pr. mirabilis and Klebsiella. Bone and joint: Infection caused by Staphylococci (penicillinase and non-penicillinase producing). Prophylactically in vaginal hysterectomy, head and neck surgery, insertion of prosthetic heart valves, and prosthetic arthroplasty. Cephalothin is not recommended for gastrointestinal procedures or other sites where anaerobic organisms such as Bacteriodes tend to prevail. Dosage is required pre-, intra-and postoperatively (i.e perioperatively, see DOSAGE AND ADMINISTRATION). If signs of postoperative infection develop, specimens should be cultured to identify the causative organism so that appropriate therapy can be instituted. NOTE: If the susceptibility tests show that the causative organism is resistant to cephalothin, other appropriate antibiotic therapy should be instituted.
Table of characteristics
|Visual appearance||white to almost white powder or plug in a 10mL type III clear glass vial, with a rubber stopper closure and aluminium flip-off top.|
|Dosage Form||Injection, powder for|
|Route of administration||Intravenous|
10 x 10mL vial: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 February 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 1 results
DBL Cephalothin Sodium for Injection (Powder for injection) - myDr.com.au
DBL Cephalothin Sodium for Injection (Powder for injection) - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results